It is a pharma private limited company based in New Delhi, Delhi, India, established in 2019.
2019 | New Delhi, Delhi, India | ActiveZarek Pharmaceuticals Private Limited, a active private limited company, was established on 20 April 2019 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24304DL2019PTC348895. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.15 M.
Its leadership includes Vitika Kumari Srivastav (Director), Kumar Pranay (Director). Past directors included Sunny Kumar, Neetu Sharma. Its latest AGM occurred on 16 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O-Mrs Heventi Devi,Plot No-D-1/12-A, Kh No-23/2,Mansa Ram Park,Uttam Nagar, New Delhi, Delhi, 110059.
U24304DL2019PTC348895
348895
20 April 2019
₹0.50 M
₹0.15 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Zarek Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vitika Kumari Srivastav | Director | 20 Apr 2019 | Current |
| Kumar Pranay | Director | 02 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Aug 2020 | Past |
| Pramod Abcsdd | Director | 11 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zarek Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.62% increase. The company also saw a substantial improvement in profitability, with a 12.15% increase in profit. The company's net worth moved up by a moderate rise of 1.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Zarek Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Zarek Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Zarek Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zarek Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Zarek Pharmaceuticals Private Limited last Annual general meeting of members was held on 16 Sep 2024 as per latest MCA records. was documented.
The activity Zarek Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Kumar Pranay was appointed as a Director was appointed as a Director on 02 Sep 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Vitika Kumari Srivastav was appointed as a Director was appointed as a Director on 20 Apr 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
The activity Zarek Pharmaceuticals Private Limited was registered on 20 Apr 2019 with Roc Delhi & aged 6 years 7 months as per MCA records. was completed.
The CIN of Zarek Pharmaceuticals Private Limited is U24304DL2019PTC348895.
Zarek Pharmaceuticals Private Limited is headquartered at C/O-Mrs Heventi Devi,Plot No-D-1/12-A, Kh No-23/2,Mansa Ram Park,Uttam Nagar, New Delhi, Delhi, 110059.
Zarek Pharmaceuticals Private Limited was incorporated on 20 April 2019.
The current directors of Zarek Pharmaceuticals Private Limited are
The primary industry of Zarek Pharmaceuticals Private Limited is Pharma.
Zarek Pharmaceuticals Private Limited is unlisted.
The authorized capital of Zarek Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.15 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX